Attacking cancer's Achilles heel: antagonism of anti‐apoptotic BCL‐2 family members - Opferman - 2016 - The FEBS Journal - Wiley Online Library
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells | Leukemia
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death | HTML
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death | HTML
Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation* - Journal of Biological Chemistry
ABT-737 - Wikipedia
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
Mechanisms of potentiation of ABT-737 lethality by strategies targeting... | Download Scientific Diagram
![ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2013/144/1/fig-8-2x.jpg "ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]")
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts - ScienceDirect
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy - Mohana‐Kumaran - 2014 - Pigment Cell & Melanoma Research - Wiley Online Library
B Cell Lymphoma 2 and Cancer Therapy | Encyclopedia MDPI
Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine | Journal of Molecular Signaling | Full Text
Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets | Arteriosclerosis, Thrombosis, and Vascular Biology
Nutrients | Free Full-Text | Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis | HTML
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas | PNAS
Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis | Future Medicinal Chemistry
Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine | Journal of Molecular Signaling | Full Text
Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT- 737 in acute myeloid leukemia - ScienceDirect
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance | Cell Death & Disease
Chemical structure and mode of action of the BH3 mimetic ABT-737 in... | Download Scientific Diagram
The regulation of MCL-1 by Noxa expression and the mechanisms of... | Download Scientific Diagram
